Literature DB >> 23532670

Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Fang Hua1, Ning Kang, Yun-An Gao, Lian-Xian Cui, De-Nian Ba, Wei He.   

Abstract

γδ T cells represent a relevant proportion of T lymphocytes that express T cell receptors (TCRs) encoded by the γ and δ T cell receptor genes. Whereas the most circulating γδ T cell type, Vδ2 T cells, has been described and studied intensively, the potential role of Vδ1 T cells remains largely unclear. Here, we identified that expanded peripheral blood Vδ1 T cells stimulated with anti-human TCR Vδ1 monoclonal antibody (mAb) in vitro predominantly expressed forkhead box p3 (Foxp3). In addition, these cells also expressed other regulatory T cell-related molecules, such as CD25, glucocorticoid-induced TNFR family-related protein and cytotoxic T lymphocyte-associated protein-4 (CTLA-4), and held the potent capacity for the production of transforming growth factor beta 1 (TGF-β1). These autocrine and/or paracrine TGF-β1 could bind TGF-β1 receptors on Vδ1 T cells and induce sustained Foxp3 expression. Moreover, Foxp3 expression coincided with high CD25 expression. CD25(high) Vδ1 T cells exhibited stronger suppression on CD4(+) T cell proliferation compared with TGF-β1-induced CD25(high) CD4(+) regulatory T cells. Therefore, our phenotypic and functional analyses first demonstrate the potential regulatory property of anti-human TCR Vδ1 mAb-activated Vδ1 T cells. These results will broaden our understanding about the role of peripheral blood Vδ1 T cells under physical and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532670     DOI: 10.1007/s12026-013-8390-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  49 in total

1.  Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

Authors:  Alessandro Poggi; Claudia Venturino; Silvia Catellani; Marino Clavio; Maurizio Miglino; Marco Gobbi; Alexander Steinle; Paolo Ghia; Stefania Stella; Federico Caligaris-Cappio; Maria Raffaella Zocchi
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

2.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.

Authors:  Ming O Li; Shomyseh Sanjabi; Richard A Flavell
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 3.  The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy.

Authors:  Rita Casetti; Angelo Martino
Journal:  Cell Mol Immunol       Date:  2008-06       Impact factor: 11.530

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

Authors:  W F Ng; P J Duggan; F Ponchel; G Matarese; G Lombardi; A D Edwards; J D Isaacs; R I Lechler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

8.  Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Authors:  Guangyong Peng; Helen Y Wang; Weiyi Peng; Yukiko Kiniwa; Kook Heon Seo; Rong-Fu Wang
Journal:  Immunity       Date:  2007-07-26       Impact factor: 31.745

9.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  20 in total

Review 1.  Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Authors:  Hamid Reza Mirzaei; Hamed Mirzaei; Sang Yun Lee; Jamshid Hadjati; Brian G Till
Journal:  Cancer Lett       Date:  2016-07-05       Impact factor: 8.679

2.  miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity.

Authors:  Yuli Zhu; Siya Zhang; Zinan Li; Huaishan Wang; Zhen Li; Yu Hu; Hui Chen; Xuan Zhang; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

Review 3.  Regulatory functions of γδ T cells.

Authors:  Christian Peters; Dieter Kabelitz; Daniela Wesch
Journal:  Cell Mol Life Sci       Date:  2018-03-08       Impact factor: 9.261

4.  Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer.

Authors:  Dang Wu; Pin Wu; Xianguo Wu; Jun Ye; Zhen Wang; Shuai Zhao; Chao Ni; Guoming Hu; Jinghong Xu; Yuehua Han; Ting Zhang; Fuming Qiu; Jun Yan; Jian Huang
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

5.  Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection.

Authors:  Iskra Tuero; David Venzon; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2016-11-04       Impact factor: 5.422

Review 6.  Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy.

Authors:  Kyle K Payne
Journal:  Immunol Invest       Date:  2016-09-12       Impact factor: 3.657

Review 7.  Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?

Authors:  Gabrielle M Siegers; Lawrence S Lamb
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

Review 8.  Human gamma delta T regulatory cells in cancer: fact or fiction?

Authors:  Daniela Wesch; Christian Peters; Gabrielle Melanie Siegers
Journal:  Front Immunol       Date:  2014-11-20       Impact factor: 7.561

9.  Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.

Authors:  Jonathan P H Fisher; Mengyong Yan; Jennifer Heuijerjans; Lisa Carter; Ayda Abolhassani; Jennifer Frosch; Rebecca Wallace; Barry Flutter; Anna Capsomidis; Mike Hubank; Nigel Klein; Robin Callard; Kenth Gustafsson; John Anderson
Journal:  Clin Cancer Res       Date:  2014-06-03       Impact factor: 12.531

Review 10.  Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.

Authors:  Priscila Ferreira Slepicka; Mahboubeh Yazdanifar; Alice Bertaina
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.